Covered recipient · General Payments record
MICHAEL E GOTTSCHALK
Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology
General Payments · PY2018–2024
$20,223.61
- Reported across 186 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $342.89 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $113.32 | 5 |
| DEXCOM, INC. | $102.94 | 5 |
| ABBVIE INC. | $43.60 | 2 |
| Azurity Pharmaceuticals, Inc. | $38.79 | 2 |
| Eton Pharmaceuticals, Inc. | $25.26 | 1 |
| SANOFI-AVENTIS U.S. LLC | $18.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.43 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103824730 | CMS |
| ABBVIE INC. | $21.17 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103824732 | CMS |
| Azurity Pharmaceuticals, Inc. | $18.36 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134006249 | CMS |
| Azurity Pharmaceuticals, Inc. | $20.43 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134006251 | CMS |
| Dexcom, Inc. | $17.51 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153322106 | CMS |
| Dexcom, Inc. | $24.09 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153322108 | CMS |
| Dexcom, Inc. | $17.68 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153322110 | CMS |
| Dexcom, Inc. | $23.57 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153322112 | CMS |
| Dexcom, Inc. | $20.09 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153322114 | CMS |
| Eton Pharmaceuticals, Inc. | $25.26 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108021324 | CMS |
| Novo Nordisk Inc | $24.93 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096666448 | CMS |
| Novo Nordisk Inc | $21.34 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097772042 | CMS |
| Novo Nordisk Inc | $20.01 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096854114 | CMS |
| Novo Nordisk Inc | $23.52 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096901185 | CMS |
| Novo Nordisk Inc | $23.52 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097473918 | CMS |
| SANOFI-AVENTIS U.S. LLC | $18.98 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139613740 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.